The word ‘TULSA’ stands for Transurethral Ultrasound Ablation. It is a minimally invasive procedure that uses directional ultrasound to produce very high temperatures to ablate (destroy) targeted prostate tissue.
The procedure is performed in a Magnetic Resonance Imaging (MRI) suite and uses the TULSA-PRO® system to ablate prostate tissue. The physician can see the prostate at all times throughout the procedure. The procedure combines real-time MRI with robotically-driven directional thermal ultrasound to deliver predictable, physician-prescribed ablation of whole-gland or partial prostate tissue.
The TULSA Procedure is radiation-free, incision-free and FDA cleared. The physician can customize the procedure depending on patients’ needs, conditions and desired functional outcomes.
The TULSA Procedure consists of four (4) stages:
The Transurethral Ultrasound Ablation (TULSA) Procedure is a minimally invasive procedure that uses directional ultrasound to produce very high temperatures to ablate (destroy) targeted prostate tissue. The procedure is performed in a Magnetic Resonance Imaging (MRI) suite and uses the TULSA-PRO® system to ablate prostate tissue from the ‘inside-out’. The procedure combines real-time MRI with robotically-driven, directional thermal ultrasound to deliver predictable, physician-prescribed ablation of whole gland or partial prostate tissue.
Whether a patient qualifies for the TULSA Procedure will be determined by the treating physician. Patients receiving the TULSA Procedure must be screened by a Magnetic Resonance Imaging professional (Radiology Technologists) before entering the MRI suite and assessed by an anesthesiologist before the procedure. In previous clinical trials, ideal candidates consisted of men with low and intermediate risk, organ-confined prostate cancer.
Patients should contact a TULSA-PRO expert at a TULSA-PRO Center to know if they qualify for the TULSA Procedure. Click here to find a TULSA-PRO Center near you.
Get the latest tips for all ages and stages. Subscribe to our newsletter.